Uncategorized
Bifrost Biosystems Launches with Novel Optical Pooled Screening Technology to Power Efficient Discovery
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #JPM24--Bifrost Biosystems announced today its launch with a vision to power efficient drug discovery through its novel automated Optical Pooled Screening (OPS) platform. The Bifrost OPS platform uniquely integrates rich, image-based, single-cell profiling data with genome-wide CRISPR perturbations. Through advanced software analysis and machine learning/artificial intelligence algorithms, the platform provides actionable, high-quality information to direct next steps